Biocon Biologics Ltd (BBL) has reached significant achievement with Health Canada's approval of Yesintek (ustekinumab injection) and Yesintek IV, which are biosimilars of Stelara and Stelara IV. The Notice of Compliance was issued on...
Eli Lilly and Cipla have signed a strategic cooperative agreement to distribute and promote tirzepatide in India. Cipla will create a new brand, Yurpeak, to expand access to the drug in areas beyond cities where Lilly is already present.
Austria's Modern Mayr Medicine, a world leader in gut health and natural preventive medicine, has announced a historic strategic relationship with Biopeak, India's first full-stack precision health and wellness platform
Aurobindo Pharma experienced an increase of 1.14%, reaching Rs 1,113.55, following the establishment of a new wholly owned subsidiary in Chile, named Eugia Pharma Chile SpA, by its wholly owned step-down subsidiary, Eugia Pharma B.V.
Johnson & Johnson announced impressive outcomes for a subcutaneous formulation of amivantamab (Rybrevant) which achieved a 45% overall response rate (ORR) in individuals with advanced head and neck squamous cell carcinoma (HNSCC)...
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of its Ropivacaine Hydrochloride Injection USP in three single-dose vial strengths
Alembic Pharmaceuticals Limited has secured final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Triamcinolone Acetonide Injectable Suspension USP
Roche revealed promising results from two pivotal Phase III trials, MEERKAT and SANDCAT, assessing vamikibart, an investigational non-steroidal medication for uveitic macular edema (UME). UME is attributable to inflammation and an accumulation...
Novartis announced that Cosentyx met its primary endpoint and all secondary endpoints in the Phase III REPLENISH study, a significant milestone in the treatment of polymyalgia rheumatica. At Week 52, Cosentyx demonstrated statistically...
Xavier School of Management, Jamshedpur, was the venue of a distinguished leadership session with Jacob Jacob, Group Chief Human Resources Officer of Aster DM Healthcare, Dubai, as part of the Aster NextGen Management
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")